Alto Neuroscience ANRO Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's common stock, par value (in dollars per share)?
- Alto Neuroscience (ANRO) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Alto Neuroscience's common stock, par value (in dollars per share) changed year-over-year?
- Alto Neuroscience's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Alto Neuroscience's common stock, par value (in dollars per share)?
- Over 2 years (2023 to 2025), Alto Neuroscience's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.